2023-2029 Global Viral Vector and Vaccine Industry Research & Trends Analysis Report
According to Latest Study, the global market for Viral Vector and Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Adenovirus segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Research Institutes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Viral Vector and Vaccine include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Viral Vector and Vaccine. Report Highlights:
(1) Global Viral Vector and Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Viral Vector and Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Viral Vector and Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Viral Vector and Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Viral Vector and Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Viral Vector and Vaccine, capacity, production and trends.
(7) Viral Vector and Vaccine industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Market segment by application, can be divided into
Research Institutes
Biopharmaceutical Companies
Others
Market segment by players, this report covers
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
1 Market Overview
1.1 Viral Vector and Vaccine Definition
1.2 Global Viral Vector and Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Viral Vector and Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Viral Vector and Vaccine Market Size, 2018-2029
1.2.3 Global Viral Vector and Vaccine Price Trend, 2018-2029
1.3 China Viral Vector and Vaccine Market Size and Forecast
1.3.1 By Revenue, China Viral Vector and Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Viral Vector and Vaccine Market Size, 2018-2029
1.3.3 China Viral Vector and Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Viral Vector and Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Viral Vector and Vaccine Share in Global Market, 2018-2029
1.4.3 Viral Vector and Vaccine Market Size: China VS Global, 2018-2029
1.5 Viral Vector and Vaccine Market Dynamics
1.5.1 Viral Vector and Vaccine Market Drivers
1.5.2 Viral Vector and Vaccine Market Restraints
1.5.3 Viral Vector and Vaccine Industry Trends
1.5.4 Viral Vector and Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Viral Vector and Vaccine Revenue by Company, 2018-2023
2.2 Global Viral Vector and Vaccine Sales Volume by Company, 2018-2023
2.3 Global Viral Vector and Vaccine Price by Company, 2018-2023
2.4 Global Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Viral Vector and Vaccine Concentration Ratio
2.6 Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Viral Vector and Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Viral Vector and Vaccine Revenue by Company, 2018-2023
3.2 China Viral Vector and Vaccine Sales Volume by Company, 2018-2023
3.3 China Viral Vector and Vaccine Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Viral Vector and Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Viral Vector and Vaccine Domestic VS Export
3.6 China Market, Viral Vector and Vaccine Import & Export
3.6.1 China Market, Viral Vector and Vaccine Import & Export, 2018-2029
3.6.2 China Viral Vector and Vaccine Import & Export Trends
3.6.3 Main Sources of China Viral Vector and Vaccine Import
3.6.4 Export Destination of China Viral Vector and Vaccine
4 Viral Vector and Vaccine Production by Region
4.1 Global Viral Vector and Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Viral Vector and Vaccine Manufacturers
4.3 Global Major Manufacturers, Viral Vector and Vaccine Capacity Expansion and Future Plans
4.4 Global Viral Vector and Vaccine Capacity by Region
4.5 Global Viral Vector and Vaccine Production by Region
4.5.1 Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Viral Vector and Vaccine Production by Region, 2018-2023
4.5.3 Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Viral Vector and Vaccine Industry Chain
5.2 Viral Vector and Vaccine Upstream Analysis
5.2.1 Viral Vector and Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Viral Vector and Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Viral Vector and Vaccine Production Mode
5.6 Viral Vector and Vaccine Procurement Model
5.7 Viral Vector and Vaccine Industry Sales Model and Sales Channels
5.7.1 Viral Vector and Vaccine Sales Model
5.7.2 Viral Vector and Vaccine Typical Distributors
6 Sights by Type
6.1 Viral Vector and Vaccine Classification
6.1.1 Adenovirus
6.1.2 Fowlpox Virus
6.1.3 Attenuated Yellow Fever
6.1.4 Vaccinia Virus Vectors
6.2 By Type, Global Viral Vector and Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Viral Vector and Vaccine Revenue, 2018-2029
6.4 By Type, Global Viral Vector and Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Viral Vector and Vaccine Price, 2018-2029
7 Sights by Application
7.1 Viral Vector and Vaccine Segment by Application
7.1.1 Research Institutes
7.1.2 Biopharmaceutical Companies
7.1.3 Others
7.2 By Application, Global Viral Vector and Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Viral Vector and Vaccine Revenue, 2018-2029
7.4 By Application, Global Viral Vector and Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Viral Vector and Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Viral Vector and Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Viral Vector and Vaccine Revenue, 2018-2029
8.3 By Region, Global Viral Vector and Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Viral Vector and Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Viral Vector and Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Viral Vector and Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Viral Vector and Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Viral Vector and Vaccine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Viral Vector and Vaccine Revenue, 2018-2029
9.3 By Country, Global Viral Vector and Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Viral Vector and Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Viral Vector and Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Viral Vector and Vaccine Market Size, 2018-2029
9.6.2 By Company, China Viral Vector and Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Viral Vector and Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Viral Vector and Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Viral Vector and Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Viral Vector and Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Viral Vector and Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Viral Vector and Vaccine Market Size, 2018-2029
9.10.2 By Company, India Viral Vector and Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Viral Vector and Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Viral Vector and Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 ABL
10.1.1 ABL Company Information, Head Office, Market Area and Industry Position
10.1.2 ABL Viral Vector and Vaccine Models, Specifications and Application
10.1.3 ABL Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 ABL Company Profile and Main Business
10.1.5 ABL Recent Developments
10.2 Addgene
10.2.1 Addgene Company Information, Head Office, Market Area and Industry Position
10.2.2 Addgene Viral Vector and Vaccine Models, Specifications and Application
10.2.3 Addgene Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Addgene Company Profile and Main Business
10.2.5 Addgene Recent Developments
10.3 Aldevron
10.3.1 Aldevron Company Information, Head Office, Market Area and Industry Position
10.3.2 Aldevron Viral Vector and Vaccine Models, Specifications and Application
10.3.3 Aldevron Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Aldevron Company Profile and Main Business
10.3.5 Aldevron Recent Developments
10.4 Boehringer Ingelheim International GmbH
10.4.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.4.2 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications and Application
10.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.4.5 Boehringer Ingelheim International GmbH Recent Developments
10.5 Brammer Bio
10.5.1 Brammer Bio Company Information, Head Office, Market Area and Industry Position
10.5.2 Brammer Bio Viral Vector and Vaccine Models, Specifications and Application
10.5.3 Brammer Bio Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Brammer Bio Company Profile and Main Business
10.5.5 Brammer Bio Recent Developments
10.6 Charles River Laboratories
10.6.1 Charles River Laboratories Company Information, Head Office, Market Area and Industry Position
10.6.2 Charles River Laboratories Viral Vector and Vaccine Models, Specifications and Application
10.6.3 Charles River Laboratories Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Charles River Laboratories Company Profile and Main Business
10.6.5 Charles River Laboratories Recent Developments
10.7 Creative-Biogene
10.7.1 Creative-Biogene Company Information, Head Office, Market Area and Industry Position
10.7.2 Creative-Biogene Viral Vector and Vaccine Models, Specifications and Application
10.7.3 Creative-Biogene Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Creative-Biogene Company Profile and Main Business
10.7.5 Creative-Biogene Recent Developments
10.8 Fujifilm Corporation
10.8.1 Fujifilm Corporation Company Information, Head Office, Market Area and Industry Position
10.8.2 Fujifilm Corporation Viral Vector and Vaccine Models, Specifications and Application
10.8.3 Fujifilm Corporation Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Fujifilm Corporation Company Profile and Main Business
10.8.5 Fujifilm Corporation Recent Developments
10.9 General Electric
10.9.1 General Electric Company Information, Head Office, Market Area and Industry Position
10.9.2 General Electric Viral Vector and Vaccine Models, Specifications and Application
10.9.3 General Electric Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 General Electric Company Profile and Main Business
10.9.5 General Electric Recent Developments
10.10 MerckKGaA
10.10.1 MerckKGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 MerckKGaA Viral Vector and Vaccine Models, Specifications and Application
10.10.3 MerckKGaA Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 MerckKGaA Company Profile and Main Business
10.10.5 MerckKGaA Recent Developments
10.11 Novasep
10.11.1 Novasep Company Information, Head Office, Market Area and Industry Position
10.11.2 Novasep Viral Vector and Vaccine Models, Specifications and Application
10.11.3 Novasep Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novasep Company Profile and Main Business
10.11.5 Novasep Recent Developments
10.12 Pfizer
10.12.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.12.2 Pfizer Viral Vector and Vaccine Models, Specifications and Application
10.12.3 Pfizer Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Pfizer Company Profile and Main Business
10.12.5 Pfizer Recent Developments
10.13 Spark Therapeutics
10.13.1 Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
10.13.2 Spark Therapeutics Viral Vector and Vaccine Models, Specifications and Application
10.13.3 Spark Therapeutics Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Spark Therapeutics Company Profile and Main Business
10.13.5 Spark Therapeutics Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
10.14.2 Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications and Application
10.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Thermo Fisher Scientific Company Profile and Main Business
10.14.5 Thermo Fisher Scientific Recent Developments
10.15 Waisman Biomanufacturing
10.15.1 Waisman Biomanufacturing Company Information, Head Office, Market Area and Industry Position
10.15.2 Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications and Application
10.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Waisman Biomanufacturing Company Profile and Main Business
10.15.5 Waisman Biomanufacturing Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Viral Vector and Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Viral Vector and Vaccine Market Restraints
Table 3. Viral Vector and Vaccine Market Trends
Table 4. Viral Vector and Vaccine Industry Policy
Table 5. Global Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Viral Vector and Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Viral Vector and Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Viral Vector and Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Viral Vector and Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Viral Vector and Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Viral Vector and Vaccine Manufacturers Product Type
Table 13. China Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Viral Vector and Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Viral Vector and Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Viral Vector and Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Viral Vector and Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Viral Vector and Vaccine Import & Export Trends
Table 19. Main Sources of China Viral Vector and Vaccine Import
Table 20. Export Destination of China Viral Vector and Vaccine
Table 21. Global Headquarters and Manufacturing Base of Viral Vector and Vaccine Manufacturers
Table 22. Global Major Manufacturers, Viral Vector and Vaccine Capacity Expansion and Future Plans
Table 23. Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Viral Vector and Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Viral Vector and Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Viral Vector and Vaccine Upstream (Raw Materials)
Table 27. Global Viral Vector and Vaccine Typical Customers
Table 28. Viral Vector and Vaccine Typical Distributors
Table 29. By Type, Global Viral Vector and Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Viral Vector and Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Viral Vector and Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Viral Vector and Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Table 39. ABL Company Information, Head Office, Market Area and Industry Position
Table 40. ABL Viral Vector and Vaccine Models, Specifications and Application
Table 41. ABL Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. ABL Company Profile and Main Business
Table 43. ABL Recent Developments
Table 44. Addgene Company Information, Head Office, Market Area and Industry Position
Table 45. Addgene Viral Vector and Vaccine Models, Specifications and Application
Table 46. Addgene Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Addgene Company Profile and Main Business
Table 48. Addgene Recent Developments
Table 49. Aldevron Company Information, Head Office, Market Area and Industry Position
Table 50. Aldevron Viral Vector and Vaccine Models, Specifications and Application
Table 51. Aldevron Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Aldevron Company Profile and Main Business
Table 53. Aldevron Recent Developments
Table 54. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 55. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications and Application
Table 56. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 58. Boehringer Ingelheim International GmbH Recent Developments
Table 59. Brammer Bio Company Information, Head Office, Market Area and Industry Position
Table 60. Brammer Bio Viral Vector and Vaccine Models, Specifications and Application
Table 61. Brammer Bio Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Brammer Bio Company Profile and Main Business
Table 63. Brammer Bio Recent Developments
Table 64. Charles River Laboratories Company Information, Head Office, Market Area and Industry Position
Table 65. Charles River Laboratories Viral Vector and Vaccine Models, Specifications and Application
Table 66. Charles River Laboratories Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Charles River Laboratories Company Profile and Main Business
Table 68. Charles River Laboratories Recent Developments
Table 69. Creative-Biogene Company Information, Head Office, Market Area and Industry Position
Table 70. Creative-Biogene Viral Vector and Vaccine Models, Specifications and Application
Table 71. Creative-Biogene Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Creative-Biogene Company Profile and Main Business
Table 73. Creative-Biogene Recent Developments
Table 74. Fujifilm Corporation Company Information, Head Office, Market Area and Industry Position
Table 75. Fujifilm Corporation Viral Vector and Vaccine Models, Specifications and Application
Table 76. Fujifilm Corporation Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Fujifilm Corporation Company Profile and Main Business
Table 78. Fujifilm Corporation Recent Developments
Table 79. General Electric Company Information, Head Office, Market Area and Industry Position
Table 80. General Electric Viral Vector and Vaccine Models, Specifications and Application
Table 81. General Electric Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. General Electric Company Profile and Main Business
Table 83. General Electric Recent Developments
Table 84. MerckKGaA Company Information, Head Office, Market Area and Industry Position
Table 85. MerckKGaA Viral Vector and Vaccine Models, Specifications and Application
Table 86. MerckKGaA Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. MerckKGaA Company Profile and Main Business
Table 88. MerckKGaA Recent Developments
Table 89. Novasep Company Information, Head Office, Market Area and Industry Position
Table 90. Novasep Viral Vector and Vaccine Models, Specifications and Application
Table 91. Novasep Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Novasep Company Profile and Main Business
Table 93. Novasep Recent Developments
Table 94. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 95. Pfizer Viral Vector and Vaccine Models, Specifications and Application
Table 96. Pfizer Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Pfizer Company Profile and Main Business
Table 98. Pfizer Recent Developments
Table 99. Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 100. Spark Therapeutics Viral Vector and Vaccine Models, Specifications and Application
Table 101. Spark Therapeutics Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Spark Therapeutics Company Profile and Main Business
Table 103. Spark Therapeutics Recent Developments
Table 104. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 105. Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications and Application
Table 106. Thermo Fisher Scientific Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Thermo Fisher Scientific Company Profile and Main Business
Table 108. Thermo Fisher Scientific Recent Developments
Table 109. Waisman Biomanufacturing Company Information, Head Office, Market Area and Industry Position
Table 110. Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications and Application
Table 111. Waisman Biomanufacturing Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Waisman Biomanufacturing Company Profile and Main Business
Table 113. Waisman Biomanufacturing Recent Developments
List of Figure
Figure 1. Viral Vector and Vaccine Picture
Figure 2. By Revenue, Global Viral Vector and Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Viral Vector and Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Viral Vector and Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Viral Vector and Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Viral Vector and Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Viral Vector and Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Viral Vector and Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Viral Vector and Vaccine Share of Global Market, 2018-2029
Figure 10. Global Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Viral Vector and Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Viral Vector and Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Viral Vector and Vaccine Domestic VS Export, 2022
Figure 16. Global Viral Vector and Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Viral Vector and Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Viral Vector and Vaccine Industry Chain
Figure 20. Viral Vector and Vaccine Procurement Model
Figure 21. Viral Vector and Vaccine Sales Model
Figure 22. Viral Vector and Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Adenovirus
Figure 24. Fowlpox Virus
Figure 25. Attenuated Yellow Fever
Figure 26. Vaccinia Virus Vectors
Figure 27. By Type, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 29. By Type, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Viral Vector and Vaccine Price, 2018-2029, (US$/Unit)
Figure 32. Research Institutes
Figure 33. Biopharmaceutical Companies
Figure 34. Others
Figure 35. By Application, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 37. By Application, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Viral Vector and Vaccine Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 41. By Region, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 42. North America Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Viral Vector and Vaccine Revenue Market Share, 2022
Figure 44. Europe Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Viral Vector and Vaccine Revenue Market Share, 2022
Figure 46. Asia Pacific Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Viral Vector and Vaccine Revenue Market Share, 2022
Figure 48. South America Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Viral Vector and Vaccine Revenue Market Share, 2022
Figure 50. Middle East & Africa Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Viral Vector and Vaccine Market Share, 2022
Figure 53. By Type, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Viral Vector and Vaccine Market Share, 2022
Figure 57. By Type, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 59. China Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Viral Vector and Vaccine Market Share, 2022
Figure 61. By Type, China Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Viral Vector and Vaccine Market Share, 2022
Figure 65. By Type, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Viral Vector and Vaccine Market Share, 2022
Figure 69. By Type, South Korea Vira
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|